Surgical Hemostats Market size was over USD 3.56 billion in 2024 and is poised to exceed USD 7.14 billion by 2037, witnessing over 5.5% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of surgical hemostats is evaluated at USD 3.72 billion. The escalating number of surgical procedures worldwide stands out as the primary catalyst propelling the growth of the surgical hemostats industry. In recent years, there has been a notable surge in both elective and emergency surgeries, contributing to an augmented need for effective hemostatic solutions since they are crucial in preventing excessive blood loss and ensuring a safe and successful surgery. According to a report by the World Health Organization (WHO), the global volume of surgical procedures is poised to exceed 300 million annually.
In addition, factors that are believed to fuel the market expansion of surgical hemostats include technological advancements. Innovations such as the development of hemostatic agents with improved clotting mechanisms and quicker onset times contribute significantly to patient outcomes. Surgeons increasingly favor these advanced technologies, appreciating their role in minimizing complications and enhancing overall surgical success rates. A study highlighted that the adoption of advanced hemostatic technologies has resulted in a 25% reduction in postoperative bleeding complications across various surgical procedures.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
5.5% |
|
Base Year Market Size (2024) |
USD 3.56 billion |
|
Forecast Year Market Size (2037) |
USD 7.14 billion |
|
Regional Scope |
|
End-Users (Hospitals, Specialty Clinics, Ambulatory Surgical Centers)
The hospitals segment is expected to hold 50% share of the global surgical hemostats market by the end of 2037. The segment is flourishing as a result of the increasing integration of technology in healthcare practices. Modern hospitals are increasingly adopting advanced technologies such as robotic-assisted surgeries, image-guided interventions, and real-time monitoring systems. Hospitals, as early adopters of these technologies, drive the demand for innovative surgical hemostats that complement and enhance these technological advancements. The integration of healthcare technologies is steadily increasing, with an annual growth rate of 15%.
Additionally, patient safety remains a paramount concern for hospitals, influencing the adoption of surgical hemostats. Effective hemostasis is a critical component of surgical care, with the potential to significantly reduce postoperative complications. Hospitals prioritize the use of hemostatic agents that contribute to positive patient outcomes by minimizing complications related to bleeding.
Formulation (Matrix & Gel, Sponge, Sheet & Pad, Powder)
The sheet & pad segment in the surgical hemostats market is set to garner a notable share shortly. Hemostat pads and sheets are multilayered materials with a self-adhering surface with a backing that resembles a sheet and are often used to regulate bleeding associated with surgery.
In addition, a hemostatic sponge promotes tissue regeneration and has antibacterial and absorbent qualities, which have been utilized in dermatologic surgery to manage postoperative hemostasis resulting from low-pressure arteriolar, venous, and capillary bleeding.
Our in-depth analysis of the surgical hemostats market includes the following segments:
|
Hemostats Type |
|
|
Formulation |
|
|
Application |
|
|
End-User |
|
North American Market Forecast
The surgical hemostats market in the region is estimated to hold a share of about 35% by the end of 2037. The market growth in the region is due to the rising spending on healthcare. As a result, companies are spending more on technological innovations in healthcare, with a particular emphasis on advanced surgical techniques. For instance, the amount spent on health care in the United States increased by around 4% in 2022 to over USD 3 trillion. The integration of robotic-assisted surgeries and other cutting-edge technologies necessitates specialized surgical hemostatic solutions. Surgeons increasingly rely on precise and efficient surgical hemostats to complement these innovations.
APAC Market Analysis
The Asia Pacific region will also encounter tremendous growth for the surgical hemostats market during the forecast period and will hold the second position owing to the rapidly growing population. With a significant proportion of the global populace residing in this region, there is a consequent increase in the demand for surgical interventions. As healthcare infrastructures expand and access to medical services improves, the number of surgeries performed in the Asia Pacific region rises, creating a substantial market for surgical hemostats to manage bleeding effectively in diverse surgical procedures.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?